BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kanellopoulos JM, Almeida-da-Silva CLC, Rüütel Boudinot S, Ojcius DM. Structural and Functional Features of the P2X4 Receptor: An Immunological Perspective. Front Immunol 2021;12:645834. [PMID: 33897694 DOI: 10.3389/fimmu.2021.645834] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Petroianu GA, Aloum L, Adem A. Neuropathic pain: Mechanisms and therapeutic strategies. Front Cell Dev Biol 2023;11:1072629. [PMID: 36727110 DOI: 10.3389/fcell.2023.1072629] [Reference Citation Analysis]
2 Steiner P, Arlt E, Boekhoff I, Gudermann T, Zierler S. TPC Functions in the Immune System. Handb Exp Pharmacol 2023. [PMID: 36639434 DOI: 10.1007/164_2022_634] [Reference Citation Analysis]
3 Chun BJ, Aryal SP, Varughese P, Sun B, Bruno JA, Richards CI, Bachstetter AD, Kekenes-Huskey PM. Purinoreceptors and ectonucleotidases control ATP-induced calcium waveforms and calcium-dependent responses in microglia: Roles of P2 receptors and CD39 in ATP-stimulated microglia. Front Physiol 2022;13:1037417. [PMID: 36699679 DOI: 10.3389/fphys.2022.1037417] [Reference Citation Analysis]
4 Janho Dit Hreich S, Juhel T, Hofman P, Vouret-Craviari V. Protocol for Evaluating In Vivo the Activation of the P2RX7 Immunomodulator. Biol Proced Online 2023;25:1. [PMID: 36600200 DOI: 10.1186/s12575-022-00188-6] [Reference Citation Analysis]
5 Volonté C, Amadio S. Rethinking purinergic concepts and updating the emerging role of P2X7 and P2X4 in amyotrophic lateral sclerosis. Neuropharmacology 2022;221:109278. [DOI: 10.1016/j.neuropharm.2022.109278] [Reference Citation Analysis]
6 Xu B, Nikolaienko O, Levchenko V, Choubey AS, Isaeva E, Staruschenko A, Palygin O. Modulation of P2X(4) receptor activity by ivermectin and 5-BDBD has no effect on the development of ARPKD in PCK rats. Physiol Rep 2022;10:e15510. [PMID: 36353932 DOI: 10.14814/phy2.15510] [Reference Citation Analysis]
7 Sudershan A, Younis M, Sudershan S, Kumar P. Migraine as an inflammatory disorder with microglial activation as a prime candidate. Neurol Res 2022;:1-16. [PMID: 36197286 DOI: 10.1080/01616412.2022.2129774] [Reference Citation Analysis]
8 Zhang WJ, Hu DX, Lin SJ, Fang XQ, Ye ZF. Contribution of P2X purinergic receptor in cerebral ischemia injury. Brain Res Bull 2022;190:42-9. [PMID: 36113681 DOI: 10.1016/j.brainresbull.2022.09.009] [Reference Citation Analysis]
9 Li X, Liu Y, Luo C, Tao J. Z1456467176 alleviates gouty arthritis by allosterically modulating P2X7R to inhibit NLRP3 inflammasome activation. Front Pharmacol 2022;13:979939. [DOI: 10.3389/fphar.2022.979939] [Reference Citation Analysis]
10 Schneider S, Merfort I, Idzko M, Zech A. Blocking P2X purinoceptor 4 signalling alleviates cigarette smoke induced pulmonary inflammation. Respir Res 2022;23. [DOI: 10.1186/s12931-022-02072-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Molnár K, Nógrádi B, Kristóf R, Mészáros Á, Pajer K, Siklós L, Nógrádi A, Wilhelm I, Krizbai IA. Motoneuronal inflammasome activation triggers excessive neuroinflammation and impedes regeneration after sciatic nerve injury. J Neuroinflammation 2022;19:68. [PMID: 35305649 DOI: 10.1186/s12974-022-02427-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
12 Yuan H, Lu B, Ji Y, Meng B, Wang R, Sun D, Liu R, Zhai X, Li X, Qin J, Chen J, Coutinho-silva R. Role of P2X4/NLRP3 Pathway-Mediated Neuroinflammation in Perioperative Neurocognitive Disorders. Mediators of Inflammation 2022;2022:1-9. [DOI: 10.1155/2022/6355805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Shinozaki C, Kohno K, Shiroishi M, Takahashi D, Yoshikawa Y, Abe Y, Hamase K, Nakakido M, Tsumoto K, Inoue K, Tsuda M, Ueda T. Improvement of the affinity of an anti-rat P2X4 receptor antibody by introducing electrostatic interactions. Sci Rep 2022;12:131. [PMID: 34996944 DOI: 10.1038/s41598-021-03784-w] [Reference Citation Analysis]
14 Barbonari S, D'amore A, Palombi F, De Cesaris P, Parrington J, Riccioli A, Filippini A. RELEVANCE OF LYSOSOMAL Ca2+ SIGNALLING MACHINERY IN CANCER. Cell Calcium 2022. [DOI: 10.1016/j.ceca.2022.102539] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Dietl P, Frick M. Channels and Transporters of the Pulmonary Lamellar Body in Health and Disease. Cells 2021;11:45. [PMID: 35011607 DOI: 10.3390/cells11010045] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Li X, Gao J, Tao J. Purinergic Signaling in the Regulation of Gout Flare and Resolution. Front Immunol 2021;12:785425. [PMID: 34925366 DOI: 10.3389/fimmu.2021.785425] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]